Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CELLTRION, INC.

(A068270)
  Rapport
Cours en clôture Korea Stock Exchange  -  30/09/2022
175500.00 KRW   +2.63%
28/09Les actions et le won sud-coréens chutent en raison des craintes de récession
ZR
05/09Les actions sud-coréennes terminent à leur plus bas niveau depuis plus de six semaines en raison des inquiétudes concernant l'énergie en Europe.
ZR
16/08Celltrion, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsFonds 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur CELLTRION, INC.
28/09Celltrion's Oncology Drug Gets Marketing Authorization in Japan
28/09S.Korean shares, won tumble on recession fears
22/09Celltrion, Abpro Partner to Develop, Commercialize Breast Cancer Treatment Drug
20/09Britain’s MHRA Clears Celltrion's Cancer Drug Vegzelma for Marketing in the UK
07/09PTAB Institutes IPRs Of Tocilzumab Patents Challenged By Celltrion
05/09S.Korean shares end at over six-week low on Europe energy worries
16/08Celltrion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Ju..
15/08Infliximab Clinical Trial Updates
09/08Celltrion Files IND With FDA For Adalimumab Biosimilar
08/08Celltrion's Net Income Jumps 41.2% in June Quarter
05/08S.Korean shares post third straight weekly gain
05/08Celltrion : 2Q 2022 Earnings Release_Celltrion Inc.
26/07Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on May 18, 2022.
26/07Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on May 18, 2022.
22/07Celltrion, Inc.'s Equity Buyback announced on May 18, 2022, has closed with 500,000 sha..
19/07Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle Eas..
27/06Celltrion Wins Sales Approval Recommendation For Its CT-P16 From European Medicines Age..
06/06Celltrion Eyes to Boost Market Share in Europe of Rheumatoid Arthritis Medication to 50..
25/05MÄRKTE ASIEN/Breite Erholung - Tokio mit Konjunktursorgen etwas leichter
25/05MÄRKTE ASIEN/Freundlich - Gelegenheitskäufe nach jüngstem Rücksetzer
18/05Celltrion, Inc. announces an Equity Buyback for 500,000 shares.
18/05Celltrion, Inc. authorizes a Buyback Plan.
16/05Celltrion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
13/05Celltrion's Net Profit Falls 39.2% in Q1; Shares Slip 6%
28/04Celltrion To Enter U.S. Humira Biosimilar Market Following Patent Agreement With AbbVie
27/04MÄRKTE ASIEN/Tokio und Seoul schwach - Erholungsrally in Schanghai
27/04MÄRKTE ASIEN/Uneinheitlich - Chinesische Börsen knapp im Plus
26/04MÄRKTE ASIEN/Flaue Erholung - Schanghai weiter im Lockdown-Tief
26/04MÄRKTE ASIEN/Börsen auf moderatem Erholungskurs
19/04Celltrion's CT-P6 Demonstrates Equivalent Safety, Efficacy With HERCEPTIN
18/04Celltrion Healthcare Starts Selling Chronic Inflammatory Disease Biosimilar Yuflyma in ..
07/04Regeneron's Disclaimer Of Aflibercept Formulation Patent Causes PTAB Denial Of Institut..
05/04Celltrion Announces Agreement With Brazilian Government To Supply Infliximab Biosimilar
01/04Regeneron Disclaims An Aflibercept Formulation Patent In Response To Celltrion PGR
29/03Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on February 21, 2022.
25/03Celltrion, Inc.'s Equity Buyback announced on February 21, 2022, has expired with 507,9..
24/03South Korea’s Kospi Falls on Higher Energy Costs, Geopolitical Woes; Samsung Elec..
22/03El Kospi de Corea sube un 0,9%, liderado por los valores de la automoción y la construc..
14/03Celltrion Shares Rally After Regulators' Ruling
08/03Celltrion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
02/03FDA warns against use of certain unauthorized COVID antigen tests
24/02El Kospi de Corea cae un 2,6% por el ataque ruso a Ucrania -- Market Talk
21/02Celltrion, Inc. announces an Equity Buyback for 507,937 shares.
21/02Celltrion, Inc. authorizes a Buyback Plan.
17/02South Korea’s Kospi Gains on US Fed’s Decision to Not Focus on Pace of Rate..
17/02Celltrion's Net Income Surges 57.3% in Q4 2021
16/02Celltrion : FY2021, 4Q21 Earning Release_Celltrion Inc.
15/02Celltrion's Biosimilar Remsima Sales Reach New High in 2021 in the US
03/02U.S. to cover cost of over-the-counter COVID tests through Medicare
21/01Three South Korean Firms to Manufacture Low-Cost Variants of Merck's COVID-19 Pill
21/01Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill
05/01Celltrion to Start Worldwide Trials of Inhalable COVID-19 Treatment; Shares Decline 3%
04/01South Korean Stocks Close Marginally Higher on Investors’ Wait-and-See Stance; LG..
04/01Celltrion's COVID-19 Treatment Drug Demonstrates Safety in Clinical Trial
2021Ema approva trattamenti contro Covid-19 di Gsk-Vir e Sobi
2021U.S. Omicron plan: boosters, free at-home tests, tighter travel rules
2021Celltrion signs COVID-19 antibody therapy supply deals with Europe
2021MÄRKTE ASIEN/Hongkong schwach - Sydney freundlich
2021U.S. secures GSK-Vir COVID-19 antibody therapy doses worth $1 billion
2021MÄRKTE ASIEN/Börsen im Wartemodus uneinheitlich
2021MÄRKTE ASIEN/Hongkong fest - Sydney schwächer
2021Celltrion Receives CHMP Positive Opinion for regdanvimab (CT-P59) as One of the First M..
2021MÄRKTE ASIEN/Etwas fester - Chinas Börsen hinken hinterher
2021MÄRKTE ASIEN/Uneinheitlich - Anleger warten auf Xi Jinping und Biden
2021Celltrion Inc. Shares Rally After EU Approves Marketing of Its Covid-19 Treatment
2021European Commission Approves Celltrion's Antibody COVID-19 Treatment
2021Celltrion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Se..
2021S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus
2021S&P Upgrades ITV To Stable From Negative On Expected Revenue Recovery
2021EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
2021MÄRKTE ASIEN/Börsen steigen - China hinkt hinterher
2021MÄRKTE ASIEN/Börsen überwiegend im Plus - Fokus auf China
2021EU Drug Regulator Backs COVID-19 Therapy from South Korea's Celltrion
2021CORONA-BLOG/EU-Kommission will Vorbereitung für Verschärfung der Lage
2021Celltrion Receives CHMP Positive Opinion for regdanvimab (CT-P59) as One of the First M..
2021EMA macht Weg frei für zwei neue Covid-Medikamente
2021Ema : via libera a 2 nuove cure contro il Covid-19
2021CORONA-BLOG/Österreich verschärft Corona-Maßnahmen weiter
2021EU-Ausschuss empfiehlt Zulassung von Roche-Covid-Medikament Ronapreve
2021CORONA-BLOG/EU-Behörde lässt Antikörper-Behandlungen gegen Covid-19 zu
2021South Korea's Kospi Closes Lower as Inflation Hits Three-Decade High in US; Celltrion L..
2021Celltrion's Net Profit Plunges 20% in Q3
2021Celltrion : 3Q 2021 Earnings Release_Celltrion Inc.
2021EU Poised To Approve Two COVID-19 Antibody Drugs
2021La UE se dispone aprobar los primeros medicamentos de anticuerpos para el COVID
2021Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
2021Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
2021Eu drugs regulator soon to approve use of regeneron-roche and celltrion monoclonal anti..
2021South Korea Stocks Inch Up as Investors Await US, China Inflation Data; SK Hynix Adds 1..
2021South Korea Stocks Decline as Investors Eye US, China Inflation Data; Biopharma Stocks ..
2021S.Korean stocks end at near 1-month low as biopharma shares slump
2021Private S.Korea firms plan $5.4 billion investment to create vaccine hub
2021Usa : al lavoro per aumentare fornitura test rapidi Covid-19
2021La UE evalúa la autorización del cóctel de anticuerpos COVID-19 de Regeneron y Roche
2021EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation
2021U.S. to invest another $1 bln in rapid COVID-19 tests
2021Covid : Ema valuta autorizzazione immissione in commercio Regkirona
2021Celltrion Awards Up to $626 Million from the Department of Defense to Supply Covid-19 P..
2021EU signs joint procurement deal for Eli Lilly COVID-19 treatment
2021180 Life Sciences : Plans Supply Deal With Celltrion Healthcare For An..
Prochain événement sur CELLTRION, INC.